Twitter Linkedin-in

R&D Series

26 - 27 May 2020 | Berlin, Germany
Book Now
R&D Series26 - 27 May 2020 | Berlin, Germany

Join over 400 leaders, experts and scientists at the renowned R&D Series, helping to shape the future of drug discovery and development

Download Agenda
Register

The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in ​therapeutic areas.

The event includes over 100 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 40 vendor companies.

Programmes

Drug Discovery Summit

An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Featuring key insights into protein degradation, AI/ML in drug discovery and updates in screening and modelling, including CRISPR and organ-on-a-chip techniques.

Drug Design & Medicinal Chemistry

Bringing you the latest in enabling technologies, computational based drug design and discovery chemistry. Key focus areas include; DNA encoded libraries, protein-protein interactions, AI/ML in drug design and medicinal chemistry for oncology.

Neuroscience Drug Discovery

The Congress will bring together a host of key experts, examining the latest advances in neuroscience research, both in target identification & validation-led approaches. Case Studies will include a focus on the tools & technologies enabling novel treatment developments and critical biomarker & translational work in preclinical development.

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Key Speakers for the 2019 Series included:

Lauren Drowley UCB

Lauren Drowley

Director, Head Functional Genomics
UCB
Denise Barrault, Scottish Universities Life Sciences Alliance

Denise Barrault

Executive Director
NPSC
Carl Petersson, Merck KGaA

Carl Petersson

Scientific Director Drug Disposition
Merck KGaA
Teemu Junttila, Genentech

Teemu Junttila

Senior Scientist, Translational Oncology
Genentech
Ingo Hartung

Ingo Hartung

Vice President of Medicinal Chemistry
Bayer AG

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Networking Drinks Reception

Relax after a busy first day at the event with access to the vibrant drink’s reception
Enquire

Gala Dinner

Sit down with your peers and fellow attendees to enjoy a 3-course meal
Enquire

Event App

Helping you get more from the event, with networking features searchable presentations & attendees, and much more
Read More

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
Quality talks / topics and high-level management presence - I really liked that the breaks are not shorter than 1 hour which is also required for networking.
Senior Sales ConsultantMimetas
Highly relevant talks for the global drug discovery and development community. A good spread of topics covering breadth and depth. At 2 days, just the right duration for a concise snapshot of today's drivers of the industry.
Senior Research FellowExperimental Drug Development Centre
High-level talks, interdisciplinary and a well-balanced mixture of industry and academia.
Head of Research PharmacokineticsBayer AG
The format allows lot of space for informal networking and there was an excellent audience, very very focused on industrial partners instead of Academic people.
Director Business Department Pharma EUBiocrates Life Sciences AG
Excellent selection of hot topics and knowledgeable speakers. Good networking setting.
Director, External Innovation in Drug DiscoverySanofi
Great chance to learn about what others are doing and to make connections with fellow scientists and providers of services.
Senior Scientific Director, Translational NeuroscienceAbbvie
Thomas Steinbrecher
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
Video Carousel Graphic
Video Insight
Video Insight Drug Discovery Summit 2019
Speaker Insight
Speaker Insight
Synthetic Biologic's VP of Research, Sheila Connelly, discusses Tackling The Antimicrobial Resistance Crisis
Webinar Insight R&D
Webinar Insight
Applications of Acoustics in Mass Spectrology, an Alternative Approach for Generation of High Content Data with John Wingfield of AstraZeneca
Daniel Zwilling INdustry Insight
Industry Insight
Daniel Zwilling, Director of CNS Discovery, Circuit Therapeutics discusses Revolutionary Optogenetic Technology

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.